SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 78.27 |
Enterprise Value ($M) | 75.03 |
Book Value ($M) | 12.65 |
Book Value / Share | 0.23 |
Price / Book | 6.19 |
NCAV ($M) | -9.91 |
NCAV / Share | -0.18 |
Price / NCAV | -7.90 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.21 |
Return on Assets (ROA) | -0.81 |
Return on Equity (ROE) | -1.54 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.78 |
Current Ratio | 1.26 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 6.15 |
Assets | 28.71 |
Liabilities | 16.06 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -31.48 |
Net Income | -32.37 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -22.85 |
Cash from Investing | -0.37 |
Cash from Financing | 4.69 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
FORM 10-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
44,017 | 136,601 | 32.22 | |
35,371 | 82,052 | 43.11 | |
28,221 | 76,087 | 37.09 | |
70,459 | 185,871 | 37.91 | |
(click for more detail) |
Similar Companies | |
---|---|
AZTR – Azitra, Inc. | CLDI – Calidi Biotherapeutics, Inc. |
CPHI – China Pharma Holdings, Inc. | CYBN – Cybin Inc. |
IBIO – iBio, Inc. |
Financial data and stock pages provided by
Fintel.io